Antimicrobial stewardship: an evidence-based, antimicrobial self-assessment toolkit (ASAT) for acute hospitals.
暂无分享,去创建一个
J. Cooke | E. Charani | W. Lawson | P. Howard | K. Hand | P. Wade | J. Richardson | T. Hills | C. Jamieson | K. Alexander
[1] Jane M. Young,et al. Audit and feedback: effects on professional practice and healthcare outcomes. , 2012, The Cochrane database of systematic reviews.
[2] Sharon Begley,et al. The best medicine. , 2011, Scientific American.
[3] P. Bonnabry,et al. Temporal effects of antibiotic use and Clostridium difficile infections. , 2009, The Journal of antimicrobial chemotherapy.
[4] A. Robinson,et al. You’re Welcome quality criteria: making health services young-people-friendly , 2009, Sexually Transmitted Infections.
[5] P. Astagneau,et al. Specific control measures for antibiotic prescription are related to lower consumption in hospitals: results from a French multicentre pilot study. , 2008, The Journal of antimicrobial chemotherapy.
[6] Jane W. Marsh,et al. Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] P. Davey,et al. Improving practice--working together to improve the use of antimicrobials. , 2007, The Journal of antimicrobial chemotherapy.
[8] K. Hand. Antibiotic pharmacists in the ascendancy. , 2007, The Journal of antimicrobial chemotherapy.
[9] P. Davey,et al. Professional education on antimicrobial prescribing: a report from the Specialist Advisory Committee on Antimicrobial Resistance (SACAR) Professional Education Subgroup. , 2007, The Journal of antimicrobial chemotherapy.
[10] J. Cooke. Report of the Prescribing Subgroup of the Specialist Advisory Committee on Antimicrobial Resistance (SACAR). , 2007, The Journal of antimicrobial chemotherapy.
[11] J. Cooke. Achieving prudence in the prescribing of antimicrobials--using clinical pharmacists in English acute hospitals. , 2007, The Journal of hospital infection.
[12] B S Cooper,et al. Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series. , 2007, The Journal of antimicrobial chemotherapy.
[13] I. Gyssens,et al. Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty: timely administration is the most important factor. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] H. Goossens,et al. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study , 2007, The Lancet.
[15] J. Burke,et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] A. Jacklin,et al. Impact of the Hospital Pharmacy Initiative for promoting prudent use of antibiotics in hospitals in England. , 2006, The Journal of antimicrobial chemotherapy.
[17] J. Lammers,et al. Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial , 2006, BMJ : British Medical Journal.
[18] D. Nathwani. Antimicrobial prescribing policy and practice in Scotland: recommendations for good antimicrobial practice in acute hospitals. , 2006, The Journal of antimicrobial chemotherapy.
[19] C. Ramsay,et al. Systematic Review of Antimicrobial Drug Prescribing in Hospitals , 2006, Emerging infectious diseases.
[20] Stuart Johnson,et al. An epidemic, toxin gene-variant strain of Clostridium difficile. , 2005, The New England journal of medicine.
[21] Ken Dewar,et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. , 2005, The New England journal of medicine.
[22] L. Lanthier,et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] K. Sepkowitz,et al. Risk Factors for Acquisition of Clostridium difficile–Associated Diarrhea among Outpatients at a Cancer Hospital , 2005, Infection Control & Hospital Epidemiology.
[24] P. Davey,et al. An outcome-based approach for teaching prudent antimicrobial prescribing to undergraduate medical students: report of a Working Party of the British Society for Antimicrobial Chemotherapy. , 2005, The Journal of antimicrobial chemotherapy.
[25] D. Livermore,et al. Minimising antibiotic resistance. , 2005, The Lancet. Infectious diseases.
[26] E. P. Dellinger,et al. Hospitals collaborate to decrease surgical site infections. , 2005, American journal of surgery.
[27] H. Goossens,et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study , 2005, The Lancet.
[28] M. Muscat,et al. Increase and change in pattern of hospital antimicrobial use, Denmark, 1997-2001. , 2004, The Journal of antimicrobial chemotherapy.
[29] Louis Valiquette,et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity , 2004, Canadian Medical Association Journal.
[30] Av Bugnon-Reber,et al. Antibiotic misuse in medium-sized Swiss hospitals. , 2004, Swiss medical weekly.
[31] M. Wilcox,et al. Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea. , 2004, The Journal of antimicrobial chemotherapy.
[32] R. Gaynes,et al. Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] J M Grimshaw,et al. Effectiveness and efficiency of guideline dissemination and implementation strategies , 2004, International Journal of Technology Assessment in Health Care.
[34] Peter Davey,et al. Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis. , 2003, The Journal of antimicrobial chemotherapy.
[35] Norma Terrin,et al. Favorable Impact of a Multidisciplinary Antibiotic Management Program Conducted During 7 Years , 2003, Infection Control & Hospital Epidemiology.
[36] J. Cheesbrough,et al. Impact of changes in antibiotic policy on Clostridium difficile-associated diarrhoea (CDAD) over a five-year period in a district general hospital. , 2003, The Journal of hospital infection.
[37] M. Stevenson,et al. Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review. , 2003, The Journal of antimicrobial chemotherapy.
[38] T. Ozawa,et al. Clostridium difficile infection associated with levofloxacin treatment. , 2002, Tennessee medicine : journal of the Tennessee Medical Association.
[39] J. Ramirez,et al. Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumoniae pneumonia. , 2001, Archives of internal medicine.
[40] M. S. Richards,et al. Early switch and early discharge strategies in patients with community-acquired pneumonia: a meta-analysis. , 2001, Archives of internal medicine.
[41] Clara C. Pratt,et al. Measuring Program Outcomes: Using Retrospective Pretest Methodology , 2000 .
[42] S. Stone,et al. Feedback is necessary in strategies to reduce hospital acquired infection , 2000, BMJ : British Medical Journal.
[43] S. S. Leger. Quick fixes for research assessment exercise will not work , 2000 .
[44] J. V. D. van der Meer,et al. Antibiotic use in Dutch hospitals 1991-1996. , 2000, The Journal of antimicrobial chemotherapy.
[45] G E Bignardi,et al. Risk factors for Clostridium difficile infection. , 1998, The Journal of hospital infection.
[46] A. Moore,et al. Antimicrobial associations of an outbreak of diarrhoea due to Clostridium difficile. , 1998, The Journal of hospital infection.
[47] P. Coudron,et al. Hospital-wide Restriction of Clindamycin: Effect on the Incidence of Clostridium difficile-Associated Diarrhea and Cost , 1998, Annals of Internal Medicine.
[48] T. Clemmer,et al. A computer-assisted management program for antibiotics and other antiinfective agents. , 1998, The New England journal of medicine.
[49] R N Baldwin,et al. Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy. , 1997, The Journal of antimicrobial chemotherapy.
[50] D. Gerding,et al. Decrease in Nosocomial Clostridium difficileAssociated Diarrhea by Restricting Clindamycin Use , 1994, Annals of Internal Medicine.
[51] David C. Classen,et al. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. , 1992, The New England journal of medicine.
[52] R. Fritz. The Path of Least Resistance , 1986 .
[53] J. Cooke,et al. Clostridium difficile infection: how to deal with the problem , 2009 .
[54] Clostridium difficile infection: how to deal with the problem , 2009 .
[55] A D Oxman,et al. Audit and feedback: effects on professional practice and health care outcomes. , 2006, The Cochrane database of systematic reviews.
[56] Jim Smith,et al. Building a safer NHS for patients: improving medication safety , 2004 .
[57] C. Normand,et al. A systematic review of the role of bisphosphonates in metastatic disease. , 2004, Health technology assessment.
[58] B. Tennison,et al. Commission for Healthcare Audit and Inspection , 2004 .
[59] L. Donaldson. Getting Ahead of the Curve. A strategy for combating infectious diseases (including other aspects of health protection) , 2002 .